SWOG S1418

Primary Category:

Treatment Protocols

Disease Category:

Adjuvant Breast, Breast



A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with > 1 cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy

Eligible for screening study DCP 001


Site Delegation of Tasks Log required prior to registration of any patients.